Dalmacito A Cordero Jr
Dalmacito A Cordero Jr
Stagnation or safety? Reassessment of the human papillomavirus vaccination dosing regimen in Japan [0.03%]
停滞还是安全？日本应重新评估人乳头瘤病毒疫苗的接种剂量方案
Mira Namba,Yudai Kaneda,Miho Iida
Mira Namba
Efficacy of oral mefenamic acid versus paracetamol as a prophylactic analgesic for needle pain in children receiving vaccination: a three-arm, parallel, triple-blind, placebo-controlled MAP VaC randomized controlled trial [0.03%]
儿童接种疫苗时口服甲灭酸与对乙酰氨基酚预防针刺疼痛有效性的比较：MAP VaC三臂平行三盲安慰剂对照随机临床试验
Rachna Pasi,Thirunavukkarasu Arun Babu,Vinoth Kumar Kallidoss
Rachna Pasi
Background: Needle pain due to routine vaccination is an important factor contributing to low vaccine adherence and immunization coverage. Prophylactic oral analgesics can address this important issue of needle pain relat...
Dalmacito A Cordero Jr
Dalmacito A Cordero Jr
Designing an inclusive immunization schedule for children and adults in India [0.03%]
在印度设计包容性的儿童和成人免疫接种时间表
Farah Niazi,Karuna Nidhi Kaur,Shazina Saeed et al.
Farah Niazi et al.
Amnuay Kleebayoon,Viroj Wiwanitkit
Amnuay Kleebayoon
Cancer vaccine strategies for the treatment of diffusely infiltrating gliomas [0.03%]
弥漫浸润性胶质瘤的癌症疫苗治疗策略
Alexander Jucht,Sydney Dumont,Channing Pooley et al.
Alexander Jucht et al.
Diffusely infiltrating gliomas - including glioblastoma (GBM), isocitrate dehydrogenase (IDH) mutant gliomas, and histone 3 (H3) altered gliomas - are primary brain tumors with an invariably fatal outcome. Despite advances in the understand...
Significant improvement of systemic lupus erythematosus manifestation in children after autologous dendritic cell transfer: a case report and review of literature [0.03%]
自体树突状细胞移植治疗儿童系统性红斑狼疮效果显著1例报告及文献复习
Jonny,Terawan Agus Putranto,Yenny Purnama et al.
Jonny et al.
Dendritic cells (DC) are postulated to play a role in autoimmune diseases such as Systemic Lupus Erythematosus (SLE). We reported a 13-year-old female SLE patient who presents with chronic arthritis accompanied by persistent fever, dyspnea,...
Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands [0.03%]
免疫检查点和癌症免疫疗法：新的潜在受体和配体研究进展
Ali N Kamali,José M Bautista,Michael Eisenhut et al.
Ali N Kamali et al.
Checkpoint markers and immune checkpoint inhibitors have been increasingly identified and developed as potential immunotherapeutic targets in various human cancers. Despite valuable efforts to discover novel immune checkpoints and their lig...
COVID-19 vaccine immune response in patients with plasma cell dyscrasia: a systematic review [0.03%]
浆细胞异常患者的新冠疫苗免疫反应：一项系统性综述
Unaiza Faizan,Lakshmi G Nair,Maroun Bou Zerdan et al.
Unaiza Faizan et al.
Background: Patients with plasma cell dyscrasia are at a higher risk of developing a severe Coronavirus-2019 (COVID-19) infection. Here we present a systematic review of clinical studies focusing on the immune response to...